HK1051039A1 - Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase. - Google Patents

Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase.

Info

Publication number: HK1051039A1
Authority: HK; Hong Kong
Prior art keywords: heteroalkylamino; inhibitors; protein kinase; substituted bicyclic; nitrogen heterocycles
Prior art date: 1999-10-21

Application number

HK03103208A

Other languages

English (en)

Inventor

James Patrick Dunn

Lawrence Emerson Fisher

David Michael Goldstein

William Harris

Christopher Huw Hill

Ian Edward David Smith

Teresa Rosanne Welch

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-21

Filing date

2003-05-06

Publication date

2003-07-18

2003-05-06 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2003-07-18 Publication of HK1051039A1 publication Critical patent/HK1051039A1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Virology (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Oncology (AREA)
Dermatology (AREA)
Hematology (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Communicable Diseases (AREA)
Cardiology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Tropical Medicine & Parasitology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Ophthalmology & Optometry (AREA)
Endocrinology (AREA)
Molecular Biology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Transplantation (AREA)

HK03103208A 1999-10-21 2003-05-06 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase. HK1051039A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US16080399P	1999-10-21	1999-10-21
US21374300P	2000-06-22	2000-06-22
PCT/EP2000/010088 WO2001029042A1 (en)	1999-10-21	2000-10-13	Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase

Publications (1)

Publication Number	Publication Date
HK1051039A1 true HK1051039A1 (en)	2003-07-18

Family

ID=26857240

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK03103208A HK1051039A1 (en)	1999-10-21	2003-05-06	Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase.

Country Status (27)

Country	Link
US (1)	US6451804B1 (zh)
EP (1)	EP1228070B1 (zh)
JP (1)	JP3961830B2 (zh)
KR (1)	KR100523120B1 (zh)
CN (1)	CN1171889C (zh)
AR (1)	AR026084A1 (zh)
AT (1)	ATE353329T1 (zh)
AU (1)	AU776250B2 (zh)
BR (1)	BR0015243A (zh)
CA (1)	CA2388142C (zh)
CZ (1)	CZ20021744A3 (zh)
DE (1)	DE60033307T2 (zh)
ES (1)	ES2280247T3 (zh)
HK (1)	HK1051039A1 (zh)
HR (1)	HRP20020328A2 (zh)
HU (1)	HUP0203564A3 (zh)
IL (1)	IL149100A0 (zh)
MA (1)	MA26837A1 (zh)
MX (1)	MXPA02003950A (zh)
NO (1)	NO20021781L (zh)
NZ (1)	NZ518119A (zh)
PE (1)	PE20010758A1 (zh)
PL (1)	PL357502A1 (zh)
RU (1)	RU2265606C2 (zh)
TR (1)	TR200201057T2 (zh)
WO (1)	WO2001029042A1 (zh)
YU (1)	YU29102A (zh)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL139599A0 (en)	1998-05-26	2002-02-10	Warner Lambert Co	Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
AU2003215675B2 (en) *	2002-04-03	2007-07-12	F. Hoffmann-La Roche Ag	Imidazo fused compounds
PL373339A1 (en) *	2002-04-19	2005-08-22	Smithkline Beecham Corporation	Novel compounds
WO2004004725A2 (en)	2002-07-09	2004-01-15	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
US7196090B2 (en)	2002-07-25	2007-03-27	Warner-Lambert Company	Kinase inhibitors
JP4252534B2 (ja) *	2002-08-06	2009-04-08	エフ．ホフマン−ラロシュアーゲー	ｐ−３８ＭＡＰキナーゼインヒビターとしての６−アルコキシ−ピリド−ピリミジン類
US7084270B2 (en) *	2002-08-14	2006-08-01	Hoffman-La Roche Inc.	Pyrimido compounds having antiproliferative activity
US7112676B2 (en) *	2002-11-04	2006-09-26	Hoffmann-La Roche Inc.	Pyrimido compounds having antiproliferative activity
TW200413381A (en)	2002-11-04	2004-08-01	Hoffmann La Roche	Novel amino-substituted dihydropyrimido [4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents
CN100357293C (zh) *	2002-11-18	2007-12-26	霍夫曼-拉罗奇有限公司	二嗪并嘧啶类
AU2004228155A1 (en) *	2003-04-10	2004-10-21	F.Hoffman-La Roche Ag	Pyrimido compounds
US7371750B2 (en)	2003-07-29	2008-05-13	Irm Llc	Compounds and compositions as protein kinase inhibitors
US20060035893A1 (en)	2004-08-07	2006-02-16	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
RU2007111757A (ru)	2004-08-31	2008-10-10	Ф.Хоффманн-Ля Рош Аг (Ch)	Амидные производные 3-фенилдигидропиримидо [4,5-d] пиримидинонов, их получение и использованиев качестве фармацевтических агентов
BRPI0514750A (pt)	2004-08-31	2008-06-24	Hoffmann La Roche	derivados amida de 7-amino-3-fenil-diidropirimido[4, 5-d]pirimidinonas, sua fabricação e uso como inibidores de proteìna cinase
WO2006038112A1 (en) *	2004-10-01	2006-04-13	Warner-Lambert Company Llc	Use of kinase inhibitors to promote neochondrogenesis
US20090131430A1 (en) *	2004-11-23	2009-05-21	Palle Venkata P	Pyrido'2,3-dipyrimidines as anti-inflammatory agents
PE20060777A1 (es)	2004-12-24	2006-10-06	Boehringer Ingelheim Int	Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
US20090036472A1 (en) *	2005-02-02	2009-02-05	Palle Venkata P	Azabicyclo derivatives as anti-inflammatory agents
JP5289972B2 (ja) *	2005-12-22	2013-09-11	ビーエーエスエフソシエタス・ヨーロピア	Ｏ−アルキル化された環式アミノアルコールの製造方法
CN101374840B (zh)	2006-01-31	2011-09-28	霍夫曼-拉罗奇有限公司	7h-吡啶并[3,4-d]嘧啶-8-酮、它们的制备及作为蛋白激酶抑制剂的应用
ES2301380B1 (es)	2006-08-09	2009-06-08	Laboratorios Almirall S.A.	Nuevos derivados de 1,7-naftiridina.
ES2320955B1 (es)	2007-03-02	2010-03-16	Laboratorios Almirall S.A.	Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
ES2329639B1 (es)	2007-04-26	2010-09-23	Laboratorios Almirall S.A.	Nuevos derivados de 4,8-difenilpoliazanaftaleno.
EP1992344A1 (en)	2007-05-18	2008-11-19	Institut Curie	P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
GB2452696B (en) *	2007-08-02	2009-09-23	Cambridge Entpr Ltd	3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
EP2108641A1 (en)	2008-04-11	2009-10-14	Laboratorios Almirall, S.A.	New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
EP2113503A1 (en)	2008-04-28	2009-11-04	Laboratorios Almirall, S.A.	New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
DK2484661T3 (en)	2009-09-30	2017-06-06	Toray Industries	2,3-DIHYDRO-1H-INDEN-2-YL URINE DERIVATIVE AND PHARMACEUTICAL USE OF SAME
EP2322176A1 (en)	2009-11-11	2011-05-18	Almirall, S.A.	New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives
WO2011065800A2 (ko) *	2009-11-30	2011-06-03	주식회사 오스코텍	피리미딘 유도체, 이의 제조방법 및 이를 함유하는 약학적 조성물
WO2012088266A2 (en)	2010-12-22	2012-06-28	Incyte Corporation	Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
CN102816162B (zh) *	2011-06-10	2016-04-27	中国科学院广州生物医药与健康研究院	嘧啶并嘧啶酮类化合物及其药用组合物和应用
HUE042374T2 (hu)	2012-06-13	2019-06-28	Incyte Holdings Corp	Szubsztituált triciklusos vegyületek mint FGFR inhibitorok
CN104540809B (zh) *	2012-07-11	2018-12-11	蓝印药品公司	成纤维细胞生长因子受体的抑制剂
US9388185B2 (en)	2012-08-10	2016-07-12	Incyte Holdings Corporation	Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
US9266892B2 (en)	2012-12-19	2016-02-23	Incyte Holdings Corporation	Fused pyrazoles as FGFR inhibitors
US9663524B2 (en)	2013-03-15	2017-05-30	Celgene Car Llc	Substituted pyrido[2,3-d]pyrimidines as protein kinase inhibitors
MY181020A (en)	2013-03-15	2020-12-16	Sanofi Sa	Heteroaryl compounds and uses thereof
AR095464A1 (es)	2013-03-15	2015-10-21	Celgene Avilomics Res Inc	Compuestos de heteroarilo y usos de los mismos
CA2909207C (en)	2013-04-19	2021-11-02	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
CN110028491B (zh)	2013-10-25	2022-02-11	缆图药品公司	纤维母细胞生长因子受体抑制剂
US10851105B2 (en)	2014-10-22	2020-12-01	Incyte Corporation	Bicyclic heterocycles as FGFR4 inhibitors
MA41551A (fr)	2015-02-20	2017-12-26	Incyte Corp	Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
WO2016134294A1 (en)	2015-02-20	2016-08-25	Incyte Corporation	Bicyclic heterocycles as fgfr4 inhibitors
AU2016219822B2 (en)	2015-02-20	2020-07-09	Incyte Holdings Corporation	Bicyclic heterocycles as FGFR inhibitors
US10308656B2 (en) *	2015-08-18	2019-06-04	Arizona Board Of Regents On Behalf Of The University Of Arizona	Small molecule inhibitors of Ku70/80 and uses thereof
KR20180002053A (ko)	2016-06-28	2018-01-05	한미약품 주식회사	신규한 헤테로시클릭 유도체 화합물 및 이의 용도
WO2018004258A1 (ko) *	2016-06-28	2018-01-04	한미약품 주식회사	신규한 헤테로시클릭 유도체 화합물 및 이의 용도
WO2018053373A1 (en)	2016-09-16	2018-03-22	The General Hospital Corporation	Uses of satl-inducible kinase (sik) inhibitors for treating osteoporosis
JP7296318B2 (ja)	2017-02-28	2023-06-22	ザジェネラルホスピタルコーポレイション	Ｓｉｋインヒビターとしてのピリミドピリミジノンの使用
AR111960A1 (es)	2017-05-26	2019-09-04	Incyte Corp	Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
CA3127373A1 (en)	2017-10-05	2019-04-11	Fulcrum Therapeutics, Inc.	P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd
US10342786B2 (en)	2017-10-05	2019-07-09	Fulcrum Therapeutics, Inc.	P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
PT3788047T (pt)	2018-05-04	2024-10-22	Incyte Corp	Formas sólidas de um inibidor de fgfr e processos para a sua preparação
SG11202010882XA (en)	2018-05-04	2020-11-27	Incyte Corp	Salts of an fgfr inhibitor
BR112021012599A2 (pt) *	2018-12-27	2021-09-08	Les Laboratoires Servier Sas	Inibidores aza-heterobicíclicos de mat2a e métodos de uso para tratamento de câncer
US11628162B2 (en)	2019-03-08	2023-04-18	Incyte Corporation	Methods of treating cancer with an FGFR inhibitor
US11591329B2 (en)	2019-07-09	2023-02-28	Incyte Corporation	Bicyclic heterocycles as FGFR inhibitors
WO2021067374A1 (en)	2019-10-01	2021-04-08	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
PE20221085A1 (es)	2019-10-14	2022-07-05	Incyte Corp	Heterociclos biciclicos como inhibidores de fgfr
US11566028B2 (en)	2019-10-16	2023-01-31	Incyte Corporation	Bicyclic heterocycles as FGFR inhibitors
GB201915828D0 (en) *	2019-10-31	2019-12-18	Cancer Research Tech Ltd	Compounds, compositions and therapeutic uses thereof
JP2023505257A (ja)	2019-12-04	2023-02-08	インサイト・コーポレイション	Ｆｇｆｒ阻害剤の誘導体
EP4069696A1 (en)	2019-12-04	2022-10-12	Incyte Corporation	Tricyclic heterocycles as fgfr inhibitors
WO2021146424A1 (en)	2020-01-15	2021-07-22	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
CA3215903A1 (en)	2021-04-12	2022-10-20	Incyte Corporation	Combination therapy comprising an fgfr inhibitor and a nectin-4 targeting agent
JP2024522189A (ja)	2021-06-09	2024-06-11	インサイト・コーポレイション	Ｆｇｆｒ阻害剤としての三環式ヘテロ環

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8814352D0 (en)	1988-06-16	1988-07-20	Smith Kline French Lab	Chemical compounds
IL117923A (en)	1995-05-03	2000-06-01	Warner Lambert Co	Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
US6147080A (en) *	1996-12-18	2000-11-14	Vertex Pharmaceuticals Incorporated	Inhibitors of p38
PL340412A1 (en) *	1997-10-20	2001-01-29	Hoffmann La Roche	Bicyclic kinase inhibitors
IL139599A0 (en) *	1998-05-26	2002-02-10	Warner Lambert Co	Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
PL347432A1 (en)	1998-10-23	2002-04-08	Hoffmann La Roche	Bicyclic nitrogen heterocycles

2000
- 2000-10-13 AU AU77873/00A patent/AU776250B2/en not_active Ceased
- 2000-10-13 KR KR10-2002-7005031A patent/KR100523120B1/ko not_active IP Right Cessation
- 2000-10-13 MX MXPA02003950A patent/MXPA02003950A/es active IP Right Grant
- 2000-10-13 IL IL14910000A patent/IL149100A0/xx unknown
- 2000-10-13 CZ CZ20021744A patent/CZ20021744A3/cs unknown
- 2000-10-13 RU RU2002112753/04A patent/RU2265606C2/ru not_active IP Right Cessation
- 2000-10-13 AT AT00967864T patent/ATE353329T1/de not_active IP Right Cessation
- 2000-10-13 TR TR2002/01057T patent/TR200201057T2/xx unknown
- 2000-10-13 BR BR0015243-9A patent/BR0015243A/pt not_active IP Right Cessation
- 2000-10-13 ES ES00967864T patent/ES2280247T3/es not_active Expired - Lifetime
- 2000-10-13 DE DE60033307T patent/DE60033307T2/de not_active Expired - Fee Related
- 2000-10-13 HU HU0203564A patent/HUP0203564A3/hu unknown
- 2000-10-13 JP JP2001531840A patent/JP3961830B2/ja not_active Expired - Fee Related
- 2000-10-13 EP EP00967864A patent/EP1228070B1/en not_active Expired - Lifetime
- 2000-10-13 WO PCT/EP2000/010088 patent/WO2001029042A1/en active Search and Examination
- 2000-10-13 YU YU29102A patent/YU29102A/sh unknown
- 2000-10-13 CN CNB008146624A patent/CN1171889C/zh not_active Expired - Fee Related
- 2000-10-13 PL PL00357502A patent/PL357502A1/xx not_active Application Discontinuation
- 2000-10-13 NZ NZ518119A patent/NZ518119A/en unknown
- 2000-10-13 CA CA002388142A patent/CA2388142C/en not_active Expired - Fee Related
- 2000-10-17 PE PE2000001104A patent/PE20010758A1/es not_active Application Discontinuation
- 2000-10-19 AR ARP000105489A patent/AR026084A1/es not_active Application Discontinuation
- 2000-10-20 US US09/693,337 patent/US6451804B1/en not_active Expired - Fee Related
2002
- 2002-04-12 HR HR20020328A patent/HRP20020328A2/hr not_active Application Discontinuation
- 2002-04-16 NO NO20021781A patent/NO20021781L/no not_active Application Discontinuation
- 2002-04-19 MA MA26612A patent/MA26837A1/fr unknown
2003
- 2003-05-06 HK HK03103208A patent/HK1051039A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
ES2280247T3 (es)	2007-09-16
MXPA02003950A (es)	2002-10-23
RU2265606C2 (ru)	2005-12-10
WO2001029042A1 (en)	2001-04-26
HUP0203564A2 (hu)	2003-02-28
PL357502A1 (en)	2004-07-26
HRP20020328A2 (en)	2004-02-29
CA2388142C (en)	2008-12-09
NO20021781D0 (no)	2002-04-16
CN1382144A (zh)	2002-11-27
AR026084A1 (es)	2002-12-26
RU2002112753A (ru)	2004-01-20
YU29102A (sh)	2004-12-31
CZ20021744A3 (cs)	2002-08-14
TR200201057T2 (tr)	2002-09-23
HUP0203564A3 (en)	2004-07-28
AU776250B2 (en)	2004-09-02
PE20010758A1 (es)	2001-07-21
AU7787300A (en)	2001-04-30
KR20020038963A (ko)	2002-05-24
MA26837A1 (fr)	2004-12-20
EP1228070B1 (en)	2007-02-07
CA2388142A1 (en)	2001-04-26
DE60033307D1 (en)	2007-03-22
EP1228070A1 (en)	2002-08-07
CN1171889C (zh)	2004-10-20
JP2003512378A (ja)	2003-04-02
KR100523120B1 (ko)	2005-10-20
BR0015243A (pt)	2002-07-16
ATE353329T1 (de)	2007-02-15
NO20021781L (no)	2002-04-18
IL149100A0 (en)	2002-11-10
DE60033307T2 (de)	2007-07-12
US6451804B1 (en)	2002-09-17
JP3961830B2 (ja)	2007-08-22
NZ518119A (en)	2004-02-27

Publication	Publication Date	Title
HK1051039A1 (en)	2003-07-18	Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase.
HK1051040A1 (en)	2003-07-18	Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase.
HK1244797A1 (zh)	2018-08-17	環蛋白酪氨酸激酶抑制劑
AP9901565A0 (en)	1999-06-30	Substituted nitrogen containing heterocycles as inhibitors of p38 protein kinase
IL137041A0 (en)	2001-06-14	Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
IL127796A0 (en)	1999-10-28	Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
HUP0400300A3 (en)	2010-12-28	Pyrrolopyrimidines as protein kinase inhibitors
IL161516A0 (en)	2004-09-27	Benzimidazoles useful as protein kinase inhibitors
HUP0202713A3 (en)	2005-02-28	Pteridinones as kinase inhibitors
AU2437900A (en)	2000-08-07	Piperidinylquinolines as protein tyrosine kinase inhibitors
PL346700A1 (en)	2002-02-25	Pyrrolopyrimidines as protein kinase inhibitors
AU2728201A (en)	2001-07-03	4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
HK1068134A1 (en)	2005-04-22	Pyrrolopyrimidines as protein kinase inhibitors
AU2576501A (en)	2001-06-18	Protein kinase inhibitors
ZA200202540B (en)	2003-06-30	Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase.
SI0951467T1 (en)	2003-10-31	SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE

Legal Events

Date	Code	Title	Description
2009-05-29	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)	Effective date: 20081013